These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36377848)

  • 61. The Diverse Roles of Arrestin Scaffolds in G Protein-Coupled Receptor Signaling.
    Peterson YK; Luttrell LM
    Pharmacol Rev; 2017 Jul; 69(3):256-297. PubMed ID: 28626043
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Role of Src in ligand-specific regulation of delta-opioid receptor desensitization and internalization.
    Hong MH; Xu C; Wang YJ; Ji JL; Tao YM; Xu XJ; Chen J; Xie X; Chi ZQ; Liu JG
    J Neurochem; 2009 Jan; 108(1):102-14. PubMed ID: 19014372
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Identification of a Conformational Equilibrium That Determines the Efficacy and Functional Selectivity of the μ-Opioid Receptor.
    Okude J; Ueda T; Kofuku Y; Sato M; Nobuyama N; Kondo K; Shiraishi Y; Mizumura T; Onishi K; Natsume M; Maeda M; Tsujishita H; Kuranaga T; Inoue M; Shimada I
    Angew Chem Int Ed Engl; 2015 Dec; 54(52):15771-6. PubMed ID: 26568421
    [TBL] [Abstract][Full Text] [Related]  

  • 64.
    Wang J; Pani B; Gokhan I; Xiong X; Kahsai AW; Jiang H; Ahn S; Lefkowitz RJ; Rockman HA
    Mol Pharmacol; 2021 Dec; 100(6):568-579. PubMed ID: 34561298
    [No Abstract]   [Full Text] [Related]  

  • 65. Insights into distinct signaling profiles of the µOR activated by diverse agonists.
    Qu Q; Huang W; Aydin D; Paggi JM; Seven AB; Wang H; Chakraborty S; Che T; DiBerto JF; Robertson MJ; Inoue A; Suomivuori CM; Roth BL; Majumdar S; Dror RO; Kobilka BK; Skiniotis G
    Nat Chem Biol; 2023 Apr; 19(4):423-430. PubMed ID: 36411392
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ligand-induced mu opioid receptor endocytosis and recycling in enteric neurons.
    Minnis JG; Patierno S; Kohlmeier SE; Brecha NC; Tonini M; Sternini C
    Neuroscience; 2003; 119(1):33-42. PubMed ID: 12763066
    [TBL] [Abstract][Full Text] [Related]  

  • 67. β-arrestin-biased signaling through the β2-adrenergic receptor promotes cardiomyocyte contraction.
    Carr R; Schilling J; Song J; Carter RL; Du Y; Yoo SM; Traynham CJ; Koch WJ; Cheung JY; Tilley DG; Benovic JL
    Proc Natl Acad Sci U S A; 2016 Jul; 113(28):E4107-16. PubMed ID: 27354517
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Biased Agonism of Endogenous Opioid Peptides at the μ-Opioid Receptor.
    Thompson GL; Lane JR; Coudrat T; Sexton PM; Christopoulos A; Canals M
    Mol Pharmacol; 2015 Aug; 88(2):335-46. PubMed ID: 26013541
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Probing the cooperative mechanism of the μ-δ opioid receptor heterodimer by multiscale simulation.
    Wang L; Yuan Y; Chen X; Chen J; Guo Y; Li M; Li C; Pu X
    Phys Chem Chem Phys; 2018 Dec; 20(47):29969-29982. PubMed ID: 30478466
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Discovery of β-arrestin-biased β
    Woo AY; Ge XY; Pan L; Xing G; Mo YM; Xing RJ; Li XR; Zhang YY; Wainer IW; Cheng MS; Xiao RP
    Acta Pharmacol Sin; 2019 Aug; 40(8):1095-1105. PubMed ID: 30643208
    [TBL] [Abstract][Full Text] [Related]  

  • 71. GPCR Heterodimerization in the Reproductive System: Functional Regulation and Implication for Biodiversity.
    Satake H; Matsubara S; Aoyama M; Kawada T; Sakai T
    Front Endocrinol (Lausanne); 2013; 4():100. PubMed ID: 23966979
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Identification of a Novel Delta Opioid Receptor Agonist Chemotype with Potential Negative Allosteric Modulator Capabilities.
    Meqbil YJ; Su H; Cassell RJ; Mores KL; Gutridge AM; Cummins BR; Chen L; van Rijn RM
    Molecules; 2021 Nov; 26(23):. PubMed ID: 34885825
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Signaling at the endosome: cryo-EM structure of a GPCR-G protein-beta-arrestin megacomplex.
    Nguyen AH; Lefkowitz RJ
    FEBS J; 2021 Apr; 288(8):2562-2569. PubMed ID: 33605032
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Biased Signaling of the G-Protein-Coupled Receptor β
    Lamichhane R; Liu JJ; White KL; Katritch V; Stevens RC; Wüthrich K; Millar DP
    Structure; 2020 Mar; 28(3):371-377.e3. PubMed ID: 31978323
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Transactivation of the PAR1-PAR2 heterodimer by thrombin elicits β-arrestin-mediated endosomal signaling.
    Lin H; Trejo J
    J Biol Chem; 2013 Apr; 288(16):11203-15. PubMed ID: 23476015
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Allosteric Effect of Nanobody Binding on Ligand-Specific Active States of the β2 Adrenergic Receptor.
    Chen Y; Fleetwood O; Pérez-Conesa S; Delemotte L
    J Chem Inf Model; 2021 Dec; 61(12):6024-6037. PubMed ID: 34780174
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A beta-arrestin binding determinant common to the second intracellular loops of rhodopsin family G protein-coupled receptors.
    Marion S; Oakley RH; Kim KM; Caron MG; Barak LS
    J Biol Chem; 2006 Feb; 281(5):2932-8. PubMed ID: 16319069
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Terminating G-Protein Coupling: Structural Snapshots of GPCR-β-Arrestin Complexes.
    Chaturvedi M; Maharana J; Shukla AK
    Cell; 2020 Mar; 180(6):1041-1043. PubMed ID: 32169216
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Measurement of β-Arrestin Recruitment at GPCRs Using the Tango Assay.
    Laroche G; Giguère PM
    Methods Mol Biol; 2019; 1947():257-267. PubMed ID: 30969421
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Sortase ligation enables homogeneous GPCR phosphorylation to reveal diversity in β-arrestin coupling.
    Staus DP; Wingler LM; Choi M; Pani B; Manglik A; Kruse AC; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 2018 Apr; 115(15):3834-3839. PubMed ID: 29581292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.